SMTI today
$31.61-$0.05 (-0.16%)close Nov 11, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourDescending Triangle
15 minDescending Triangle
5 minDescending Triangle
Daily trend turns up above $35.34
Key levels
Resistance$34.99
Resistance$33.99
Support$30.40
Support$29.05
Latest news & SEC filings
DealSanara Medtech divests Tissue Health Plus unit assets for about $2M
All SMTI news →About Sanara MedTech
Sanara MedTech is a medical technology company that develops and sells products for the surgical market. Its main offerings include soft tissue repair products such as CellerateRX Surgical Powder and BIASURGE, and bone fusion products like BiFORM and ALLOCYTE Plus. The company sells primarily to hospitals and ambulatory surgical centers in the United States, targeting surgeons and healthcare systems. It also has a research and development team focused on next-generation surgical products.
Based on the company's 10-K filed Mar 24, 2026.
Nasdaq · Healthcare
Sanara MedTech Inc. (SMTI)
What Is the Price Target for SMTI?
SEPT Low Target
$28.47
SEPT Mid Target
$33.50
SEPT High Target
$38.52
Analyst Consensus
$33.50
Is SMTI a Buy or Sell Right Now?
Thesis
- •Revenue growing 19.0% YoY with STRONG trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for SMTI.
Start Free Trial →Is SMTI Overvalued or Undervalued?
Valuation Verdict
OVERVALUED
Methods Used
P/E Forward, P/B, Analyst Consensus
Fair Value
$23.66
31
Moat Score
NONE
4/9
Piotroski Score
3.3
Altman Z-Score
What Is Smart Money Doing with SMTI?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| TANZBERGER ERIC D | director | Buy | 5,308 | - | Jun 4, 2026 |
| Salamone Ann Beal | director | Buy | 4,154 | - | Jun 4, 2026 |
| Ortwein Sara N | director | Buy | 4,616 | - | Jun 4, 2026 |
| Nixon Ronald T | director 10% owner | Buy | 4,154 | - | Jun 4, 2026 |
| Myers Keith G | director | Buy | 4,385 | - | Jun 4, 2026 |
| Major Eric D | director | Buy | 4,846 | - | Jun 4, 2026 |
| Mack Roszell III | director | Buy | 5,308 | - | Jun 4, 2026 |
| DeSutter Robert Andrew | director | Buy | 5,539 | - | Jun 4, 2026 |
| Yon Seth D | director officer | Sale | 3,852 | $81K | May 15, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →SMTI Growth Story
Revenue YoY
19.0%
3yr Revenue CAGR
31.0%
EPS Growth YoY
-282.46%
FCF Growth YoY
1041.1%
Revenue Trend
STRONG
Dark Pool Trades for SMTI
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for SMTI, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:51:42 | $32.00 | 2,000 | $$64K | SELL |
| 14:51:42 | $31.58 | 1,800 | $$57K | SELL |
| 14:51:33 | $32.25 | 4,112 | $$133K | SELL |
| 14:43:48 | $32.25 | 2,000 | $$65K | MIDPOINT |
| 18:48:32 | $32.08 | 1,100 | $$35K | SELL |
5 dark pool trades shown · $$353K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Sanara MedTech Inc. (SMTI) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →SMTI — frequently asked questions
What is SMTI stock price today?
Sanara MedTech Inc. (SMTI) is at $31.61, down 0.16% (-$0.05) at the Nov 11, 2026 close.
Why is SMTI stock moving today?
Latest SMTI news — Oct 29, 2026: Sanara Medtech divests Tissue Health Plus unit assets for about $2M
What is the SMTI price target?
The average analyst price target for SMTI is $33.50, ranging from $32 to $35, based on 2 analysts. Latest: HC Wainwright & Co. downgrade on Jul 30, 2026.
What do analysts rate SMTI?
Analyst ratings for SMTI: 0 Buy, 1 Hold, 1 Sell — consensus Hold.
Did SMTI beat earnings?
SMTI last reported on Aug 12, 2026: EPS -$0.05 vs $0.02 expected — a miss of 350.0%.
Does SMTI pay a dividend?
SMTI does not currently pay a dividend.
How much debt does SMTI have?
Sanara MedTech Inc. reported $46M of debt and $15M of cash (Jun 30, 2026).
What are SMTI support and resistance levels?
Support: $30.40, $29.05, $27.00. Resistance: $33.99, $34.99.
What are insiders doing with SMTI?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on SMTI?
Oct 29, 2026: Sanara Medtech divests Tissue Health Plus unit assets for about $2M